Melperone treatment in an organic delusional syndrome induced by hyperprolactinemia: A case report

Soygur H., Palaoglu O., Altinors N., Corapcioglu D., Erdogan G., Ayhan I.

EUROPEAN NEUROPSYCHOPHARMACOLOGY, vol.7, no.2, pp.161-163, 1997 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 7 Issue: 2
  • Publication Date: 1997
  • Doi Number: 10.1016/s0924-977x(96)00387-2
  • Journal Name: EUROPEAN NEUROPSYCHOPHARMACOLOGY
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.161-163
  • Keywords: melperone, organic delusional syndrome, hyperprolactinemia, SCHIZOPHRENIA
  • Ankara University Affiliated: No

Abstract

A young female with organic delusional syndrome induced by hyperprolactinemia was admitted to the Psychiatry Clinic of Ankara Social Security Hospital. The most striking characteristic of her history was either worsening of the endocrinologic clinical outcome under conventional neuroleptic treatment or worsening of clinical psychiatric outcome under bromocriptine therapy. A new atypical neuroleptic, melperone, suggested to minimally affect plasma prolactin levels, was started. Her psychotic complaints significantly subsided and she was devoid of any symptomatological change regarding her endocrinological status. These results were discussed. (C) 1997 Elsevier Science B.V.